Skopos Labs, Inc. Spring Works Therapeutics, Inc. Transaction History
Skopos Labs, Inc.
- $453 Million
- Q1 2025
A detailed history of Skopos Labs, Inc. transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Skopos Labs, Inc. holds 10 shares of SWTX stock, worth $462. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10Holding current value
$462% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SWTX
# of Institutions
361Shares Held
63.1MCall Options Held
5.81MPut Options Held
2.55M-
Vanguard Group Inc Valley Forge, PA7.08MShares$327 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$260 Million0.0% of portfolio
-
State Street Corp Boston, MA2.92MShares$135 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.58MShares$119 Million0.01% of portfolio
-
Woodline Partners LP San Francisco, CA2.14MShares$99.1 Million0.66% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.88B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...